Modeling Host Genetic Regulation of Influenza Pathogenesis in the Collaborative Cross

PLoS Pathogens

Volumn 9, Issue 2, 2013, Pages

  Ferris, Martin T ^a,b,c   Aylor, David L ^b   Bottomly, Daniel ^c,d   Whitmore, Alan C ^a   Aicher, Lauri D ^c,e   Bell, Timothy A ^b   Bradel Tretheway, Birgit ^c,e   Bryan, Janine T ^c,e   Buus, Ryan J ^b   Gralinski, Lisa E ^a,f   Haagmans, Bart L ^g   McMillan, Leonard ^a   Miller, Darla R ^b   Rosenzweig, Elizabeth ^c,e   Valdar, William ^b   Wang, Jeremy ^a   Churchill, Gary A ^h   Threadgill, David W ⁱ   McWeeney, Shannon K ^c,d   Katze, Michael G ^c,e   Pardo Manuel de Villena, Fernando ^a,b,c   Baric, Ralph S ^a,d,f   Heise, Mark T ^a,b,c   more..

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c Pacific Northwest Regional Cntr of Excellence for Biodefense and Emerging Infectious Diseases Res   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^f IL   (United States)

^g ERASMUS MEDICAL CENTER   (Netherlands)

^h JACKSON LABORATORY   (United States)

ⁱ NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; FEMALE; GENE; GENE MAPPING; GENETIC POLYMORPHISM; GENETIC REGULATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INFLUENZA; INFLUENZA VIRUS A; LUNG EDEMA; MORBIDITY; MOUSE; MX1 GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; QUANTITATIVE TRAIT LOCUS; REAL TIME POLYMERASE CHAIN REACTION; TISSUE MICROARRAY; VIRUS PATHOGENESIS; VIRUS REPLICATION; WEIGHT REDUCTION;

ANIMALS; CROSSES, GENETIC; FEMALE; GENETIC VARIATION; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; LUNG; MICE; MICE, INBRED STRAINS; MODELS, GENETIC; ORTHOMYXOVIRIDAE INFECTIONS; PHENOTYPE; REASSORTANT VIRUSES; RECOMBINATION, GENETIC; RODENT DISEASES; SPECIES SPECIFICITY; VIRUS REPLICATION;

EID: 84880944577     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003196     Document Type: Article

References (101)

1. Watanabe T, Kawaoka Y, (2011) Pathogenesis of the 1918 pandemic influenza virus. PLoS Pathog 7 (1): e1001218 10.1371/journal.ppat.1001218.
2. Pabst D, Kuehn J, Schuler-Luettmann S, Wiebe K, Lebiedz P, (2011) Acute respiratory distress syndrome as a presenting manifestation in young patients infected with H1N1 influenza virus. Eur J Intern Med 22 (6): e119-24 10.1016/j.ejim.2011.08.014.
3. Tsalik EL, Hendershot EF, Sangvai DG, Cunningham HM, Cunningham CK, et al. (2010) Clinical presentation and response to treatment of novel influenza A H1N1 in a university-based summer camp population. J Clin Virol 47 (3): 286-288 10.1016/j.jcv.2009.12.012.
4. To KK, Hung IF, Li IW, Lee KL, Koo CK, et al. (2010) Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection. Clin Infect Dis 50 (6): 850-859 10.1086/650581.
5. Yu H, Gao Z, Feng Z, Shu Y, Xiang N, et al. (2008) Clinical characteristics of 26 human cases of highly pathogenic avian influenza A (H5N1) virus infection in china. PLoS One 3 (8): e2985 10.1371/journal.pone.0002985.
6. Prasad HB, Puranik SC, Kadam DB, Sangle SA, Borse RT, et al. (2011) Retrospective analysis of necropsy findings in patients of H1N1 and their correlation to clinical features. J Assoc Physicians India 59: 498-500.
7. Mallia P, Johnston SL, (2007) Influenza infection and COPD. Int J Chron Obstruct Pulmon Dis 2 (1): 55-64.
8. Li G, Yilmaz M, Kojicic M, Fernandez-Perez E, Wahab R, et al. (2009) Outcome of critically ill patients with influenza virus infection. J Clin Virol 46 (3): 275-278 10.1016/j.jcv.2009.07.015.
9. Beigel JH, Farrar J, Han AM, Hayden FG, Hyer R, et al. (2005) Avian influenza A (H5N1) infection in humans. N Engl J Med 353 (13): 1374-1385.
10. Zaas AK, Chen M, Varkey J, Veldman T, Hero AO 3rd, et al. (2009) Gene expression signatures diagnose influenza and other symptomatic respiratory viral infections in humans. Cell Host Microbe 6 (3): 207-217 10.1016/j.chom.2009.07.006.
11. Igusa R, Sakakibara T, Shibahara T, Sakamoto K, Nishimura H, et al. (2012) Complicated secondary pneumonia after swine-origin influenza a virus infection in an immunocompetent patient. Tohoku J Exp Med 226 (2): 117-120.
12. Luyt CE, Combes A, Trouillet JL, Nieszkowska A, Chastre J, (2011) Virus-induced acute respiratory distress syndrome: Epidemiology, management and outcome. Presse Med 40 (12 Pt 2): e561-8 10.1016/j.lpm.2011.05.027.
13. Rothberg MB, Haessler SD, Brown RB, (2008) Complications of viral influenza. Am J Med 121 (4): 258-264 10.1016/j.amjmed.2007.10.040.
14. Shapira SD, Gat-Viks I, Shum BO, Dricot A, de Grace MM, et al. (2009) A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection. Cell 139 (7): 1255-1267 10.1016/j.cell.2009.12.018.
15. Brass AL, Huang IC, Benita Y, John SP, Krishnan MN, et al. (2009) The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, west nile virus, and dengue virus. Cell 139 (7): 1243-1254 10.1016/j.cell.2009.12.017.
16. Albright FS, Orlando P, Pavia AT, Jackson GG, Cannon Albright LA, (2008) Evidence for a heritable predisposition to death due to influenza. J Infect Dis 197 (1): 18-24.
17. Eisen DP, (2010) Mannose-binding lectin deficiency and respiratory tract infection. J Innate Immun 2 (2): 114-122 10.1159/000228159.
18. Huang Y, Paxton WA, Wolinsky SM, Neumann AU, Zhang L, et al. (1996) The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat Med 2 (11): 1240-1243.
19. Rauch A, Kutalik Z, Descombes P, Cai T, Di Iulio J, et al. (2010) Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: A genome-wide association study. Gastroenterology 138 (4): 1338-45, 1345.e1-7 10.1053/j.gastro.2009.12.056.
20. Lindesmith L, Moe C, Marionneau S, Ruvoen N, Jiang X, et al. (2003) Human susceptibility and resistance to norwalk virus infection. Nat Med 9 (5): 548-553 10.1038/nm860.
21. Zhang H, Zhou G, Zhi L, Yang H, Zhai Y, et al. (2005) Association between mannose-binding lectin gene polymorphisms and susceptibility to severe acute respiratory syndrome coronavirus infection. J Infect Dis 192 (8): 1355-1361.
22. Shaw S, Biddison WE, (1979) HLA-linked genetic control of the specicity of human cytotoxic T-cell responses to influenza virus. J Exp Med 149 (3): 565-575.
23. Mackenzie JS, Wetherall JD, Flower RL, Fimmel PJ, Dawkins RL, (1979) HLA antigens and the response to influenza A virus. Vox Sang 37 (4): 201-208.
24. Crighton EJ, Moineddin R, Mamdani M, Upshur RE, (2004) Influenza and pneumonia hospitalizations in ontario: A time-series analysis. Epidemiol Infect 132 (6): 1167-1174.
25. Hui DS, (2008) Influenza A/H5N1 infection: Other treatment options and issues. Respirology 13 Suppl 1: S22-6 10.1111/j.1440-1843.2008.01250.x.
26. Irwin DE, Weatherby LB, Huang WY, Rosenberg DM, Cook SF, et al. (2001) Impact of patient characteristics on the risk of influenza/ILI-related complications. BMC Health Serv Res 1 (1): 8.
27. Staeheli P, Grob R, Meier E, Sutcliffe JG, Haller O, (1988) Influenza virus-susceptible mice carry mx genes with a large deletion or a nonsense mutation. Mol Cell Biol 8 (10): 4518-4523.
28. Dawson TC, Beck MA, Kuziel WA, Henderson F, Maeda N, (2000) Contrasting effects of CCR5 and CCR2 deficiency in the pulmonary inflammatory response to influenza A virus. Am J Pathol 156 (6): 1951-1959.
29. Karupiah G, Chen JH, Mahalingam S, Nathan CF, MacMicking JD, (1998) Rapid interferon gamma-dependent clearance of influenza A virus and protection from consolidating pneumonitis in nitric oxide synthase 2-deficient mice. J Exp Med 188 (8): 1541-1546.
30. Kopf M, Abel B, Gallimore A, Carroll M, Bachmann MF, (2002) Complement component C3 promotes T-cell priming and lung migration to control acute influenza virus infection. Nat Med 8 (4): 373-378.
31. Kozak W, Zheng H, Conn CA, Soszynski D, van der Ploeg LH, et al. (1995) Thermal and behavioral effects of lipopolysaccharide and influenza in interleukin-1 beta-deficient mice. Am J Physiol 269 (5 Pt 2): R969-77.
32. Koyama S, Ishii KJ, Kumar H, Tanimoto T, Coban C, et al. (2007) Differential role of TLR- and RLR-signaling in the immune responses to influenza A virus infection and vaccination. J Immunol 179 (7): 4711-4720.
33. Liu B, Mori I, Hossain MJ, Dong L, Takeda K, et al. (2004) Interleukin-18 improves the early defence system against influenza virus infection by augmenting natural killer cell-mediated cytotoxicity. J Gen Virol 85 (Pt 2): 423-428.
34. Marsland BJ, Schmitz N, Kopf M, (2005) IL-4Ralpha signaling is important for CD8+ T cell cytotoxicity in the absence of CD4+ T cell help. Eur J Immunol 35 (5): 1391-1398 10.1002/eji.200425768.
35. Schmitz N, Kurrer M, Bachmann MF, Kopf M, (2005) Interleukin-1 is responsible for acute lung immunopathology but increases survival of respiratory influenza virus infection. J Virol 79 (10): 6441-6448 10.1128/JVI.79.10.6441-6448.2005.
36. Tecle T, White MR, Hartshorn KL, (2005) Innate immunity to influenza A virus. Current Respiratory Medicine Reviews 1 (1): 127-145.
37. Schmolke M, Garcia-Sastre A, (2010) Evasion of innate and adaptive immune responses by influenza A virus. Cell Microbiol 12 (7): 873-880 10.1111/j.1462-5822.2010.01475.x.
38. Imai Y, Kuba K, Neely GG, Yaghubian-Malhami R, Perkmann T, et al. (2008) Identification of oxidative stress and toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell 133 (2): 235-249.
39. Lin KL, Suzuki Y, Nakano H, Ramsburg E, Gunn MD, (2008) CCR2+ monocyte-derived dendritic cells and exudate macrophages produce influenza-induced pulmonary immune pathology and mortality. J Immunol 180 (4): 2562-2572.
40. Szretter KJ, Gangappa S, Lu X, Smith C, Shieh WJ, et al. (2007) Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice. J Virol 81 (6): 2736-2744.
41. Bender BS, Taylor SF, Zander DS, Cottey R, (1995) Pulmonary immune response of young and aged mice after influenza challenge. J Lab Clin Med 126 (2): 169-177.
42. Boon AC, deBeauchamp J, Hollmann A, Luke J, Kotb M, et al. (2009) Host genetic variation affects resistance to infection with a highly pathogenic H5N1 influenza A virus in mice. J Virol 83 (20): 10417-10426 10.1128/JVI.00514-09.
43. Asanuma H, Hirokawa K, Uchiyama M, Suzuki Y, Aizawa C, et al. (2001) Immune responses and protection in different strains of aged mice immunized intranasally with an adjuvant-combined influenza vaccine. Vaccine 19 (28-29): 3981-3989.
44. Srivastava B, Blazejewska P, Hessmann M, Bruder D, Geffers R, et al. (2009) Host genetic background strongly influences the response to influenza a virus infections. PLoS One 4 (3): e4857 10.1371/journal.pone.0004857.
45. Boivin GA, Pothlichet J, Skamene E, Brown EG, Loredo-Osti JC, et al. (2012) Mapping of clinical and expression quantitative trait loci in a sex-dependent effect of host susceptibility to mouse-adapted influenza H3N2/HK/1/68. J Immunol 188 (8): 3949-3960 10.4049/jimmunol.1103320.
46. Nedelko T, Kollmus H, Klawonn F, Spijker S, Lu L, et al. (2012) Distinct gene loci control the host response to influenza H1N1 virus infection in a time-dependent manner. BMC Genomics 13 (1): 411 10.1186/1471-2164-13-411.
47. Yang H, Bell TA, Churchill GA, Pardo-Manuel de Villena F, (2007) On the subspecific origin of the laboratory mouse. Nat Genet 39 (9): 1100-1107.
48. Churchill GA, Airey DC, Allayee H, Angel JM, Attie AD, et al. (2004) The collaborative cross, a community resource for the genetic analysis of complex traits. Nat Genet 36 (11): 1133-1137.
49. Aylor DL, Valdar W, Foulds-Mathes W, Buus RJ, Verdugo RA, et al. (2011) Genetic analysis of complex traits in the emerging collaborative cross. Genome Res 21: 1213-22 10.1101/gr.111310.110.
50. Chesler EJ, Miller DR, Branstetter LR, Galloway LD, Jackson BL, et al. (2008) The collaborative cross at oak ridge national laboratory: Developing a powerful resource for systems genetics. Mamm Genome 19 (6): 382-389.
51. Philip VM, Sokoloff G, Ackert-Bicknell CL, Striz M, Branstetter L, et al. (2011) Genetic analysis in the collaborative cross breeding population. Genome Res 21 (8): 1223-1238 10.1101/gr.113886.110.
52. Collaborative Cross Consortium (2012) The genome architecture of the collaborative cross mouse genetic reference population. Genetics 190 (2): 389-401 10.1534/genetics.111.132639.
53. Fuller TF, Ghazalpour A, Aten JE, Drake TA, Lusis AJ, et al. (2007) Weighted gene coexpression network analysis strategies applied to mouse weight. Mamm Genome 18 (6-7): 463-472 10.1007/s00335-007-9043-3.
54. Bottomly D, Ferris MT, Aicher LD, Rosenzweig E, Whitmore A, et al. (2012) Expression quantitative trait loci for extreme host response to influenza A in pre-collaborative cross mice. Genes, Genomes, Genetics 2 (2): 213-221.
55. Kelada SN, Aylor DL, Peck BC, Ryan JF, Tavarez U, et al. (2012) Genetic analysis of hematological parameters in incipient lines of the collaborative cross. G3 (Bethesda) 2 (2): 157-165 10.1534/g3.111.001776.
56. Jin HK, Yamashita T, Ochiai K, Haller O, Watanabe T, (1998) Characterization and expression of the Mx1 gene in wild mouse species. Biochem Genet 36 (9-10): 311-322.
57. Keane TM, Goodstadt L, Danecek P, White MA, Wong K, et al. (2011) Mouse genomic variation and its effect on phenotypes and gene regulation. Nature 477 (7364): 289-294 10.1038/nature10413; 10.1038/nature10413.
58. Yang H, Wang JR, Didion JP, Buus RJ, Bell TA, et al. (2011) Subspecific origin and haplotype diversity in the laboratory mouse. Nat Genet 43 (7): 648-655 10.1038/ng.847; 10.1038/ng.847.
59. Ma W, Xia C, Ling P, Qiu M, Luo Y, et al. (2001) Leukocyte-specific adaptor protein Grap2 interacts with hematopoietic progenitor kinase 1 (HPK1) to activate JNK signaling pathway in T lymphocytes. Oncogene 20 (14): 1703-1714 10.1038/sj.onc.1204224.
60. Cruikshank WW, Kornfeld H, Center DM, (2000) Interleukin-16. J Leukoc Biol 67 (6): 757-766.
61. Park HS, Jung HY, Park EY, Kim J, Lee WJ, et al. (2004) Cutting edge: Direct interaction of TLR4 with NAD(P)H oxidase 4 isozyme is essential for lipopolysaccharide-induced production of reactive oxygen species and activation of NF-kappa B. J Immunol 173 (6): 3589-3593.
62. Roberts A, Deming D, Paddock CD, Cheng A, Yount B, et al. (2007) A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice. PLoS Pathog 3 (1): e5 10.1371/journal.ppat.0030005.
63. Tumpey TM, Basler CF, Aguilar PV, Zeng H, Solorzano A, et al. (2005) Characterization of the reconstructed 1918 spanish influenza pandemic virus. Science 310 (5745): 77-80.
64. Tumpey TM, Garcia-Sastre A, Taubenberger JK, Palese P, Swayne DE, et al. (2005) Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: Functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice. J Virol 79 (23): 14933-14944.
65. Damjanovic D, Divangahi M, Kugathasan K, Small CL, Zganiacz A, et al. (2011) Negative regulation of lung inflammation and immunopathology by TNF-alpha during acute influenza infection. Am J Pathol 179 (6): 2963-2976 10.1016/j.ajpath.2011.09.003.
66. Boon AC, Finkelstein D, Zheng M, Liao G, Allard J, et al. (2011) H5N1 influenza virus pathogenesis in genetically diverse mice is mediated at the level of viral load. MBio 2 (5) 10.1128/mBio.00171-11. Print 2011. 10.1128/mBio.00171-11; 10.1128/mBio.00171-11.
67. Mackenzie JS, Wetherall JD, Fimmel PJ, Hawkins BR, Dawkins RL, (1977) Host factors and susceptibility to influenza A infection: The effect of ABO blood groups and HL-A antigens. Dev Biol Stand 39: 355-362.
68. Tumpey TM, Szretter KJ, Van Hoeven N, Katz JM, Kochs G, et al. (2007) The Mx1 gene protects mice against the pandemic 1918 and highly lethal human H5N1 influenza viruses. J Virol 81 (19): 10818-10821.
69. Bosco EE, Kumar S, Marchioni F, Biesiada J, Kordos M, et al. (2012) Rational design of small molecule inhibitors targeting the rac GTPase-p67(phox) signaling axis in inflammation. Chem Biol 19 (2): 228-242 10.1016/j.chembiol.2011.12.017.
70. Tzircotis G, Braga VM, Caron E, (2011) RhoG is required for both FcgammaR- and CR3-mediated phagocytosis. J Cell Sci 124 (Pt 17): 2897-2902 10.1242/jcs.084269.
71. Brinton MA, Perelygin AA, (2003) Genetic resistance to flaviviruses. Adv Virus Res 60: 43-85.
72. Scalzo AA, Fitzgerald NA, Simmons A, La Vista AB, Shellam GR, (1990) Cmv-1, a genetic locus that controls murine cytomegalovirus replication in the spleen. J Exp Med 171 (5): 1469-1483.
73. Govoni G, Gros P, (1998) Macrophage NRAMP1 and its role in resistance to microbial infections. Inflamm Res 47 (7): 277-284.
74. Allison AC, (1954) Protection afforded by sickle-cell trait against subtertian malareal infection. Br Med J 1 (4857): 290-294.
75. Marchiori E, Zanetti G, Fontes CA, Santos ML, Valiante PM, et al. (2011) Influenza A (H1N1) virus-associated pneumonia: High-resolution computed tomography-pathologic correlation. Eur J Radiol 80 (3): e500-4 10.1016/j.ejrad.2010.10.003.
76. Ishigaki H, Sai S, Shirai M, Hongo T, (2011) Critical findings of severe influenza A (H1N1) pneumonia in children. Pediatr Int 53 (5): 669-671 10.1111/j.1442-200X.2011.03324.x; 10.1111/j.1442-200X.2011.03324.x.
77. Didion JP, Yang H, Sheppard K, Fu CP, McMillan L, et al. (2012) Discovery of novel variants in genotyping arrays improves genotype retention and reduces ascertainment bias. BMC Genomics 3: 34 10.1186/1471-2164-13-34.
78. Benovoy D, Kwan T, Majewski J, (2008) Effect of polymorphisms within probe-target sequences on olignonucleotide microarray experiments. Nucleic Acids Res 36 (13): 4417-4423 10.1093/nar/gkn409.
79. Mauad T, Hajjar LA, Callegari GD, da Silva LF, Schout D, et al. (2010) Lung pathology in fatal novel human influenza A (H1N1) infection. Am J Respir Crit Care Med 181 (1): 72-79 10.1164/rccm.200909-1420OC.
80. Nakaya HI, Wrammert J, Lee EK, Racioppi L, Marie-Kunze S, et al. (2011) Systems biology of vaccination for seasonal influenza in humans. Nat Immunol 12 (8): 786-795 10.1038/ni.2067; 10.1038/ni.2067.
81. Perrone LA, Plowden JK, Garcia-Sastre A, Katz JM, Tumpey TM, (2008) H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice. PLoS Pathog 4 (8): e1000115.
82. Peper RL, Van Campen H, (1995) Tumor necrosis factor as a mediator of inflammation in influenza A viral pneumonia. Microb Pathog 19 (3): 175-183.
83. Newport MJ, Finan C, (2011) Genome-wide association studies and susceptibility to infectious diseases. Brief Funct Genomics 10 (2): 98-107 10.1093/bfgp/elq037.
84. Shrestha S, (2011) Influence of host genetic and ecological factors in complex concomitant infections- relevance to sexually transmitted infections. J Reprod Immunol 92 (1-2): 27-32 10.1016/j.jri.2011.09.001.
85. Pasieka TJ, Cilloniz C, Lu B, Teal TH, Proll SC, et al. (2009) Host responses to wild-type and attenuated herpes simplex virus infection in the absence of Stat1. J Virol 83 (5): 2075-2087 10.1128/JVI.02007-08.
86. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, et al. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4 (2): 249-264 10.1093/biostatistics/4.2.249.
87. Bolstad BM, Irizarry RA, Astrand M, Speed TP, (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19 (2): 185-193.
88. Smyth G. (2005) Limma: Linear models for microarray data. New York: Springer.
89. Storey JD, Tibshirani R, (2003) Statistical significance for genomewide studies. Proc Natl Acad Sci U S A 100 (16): 9440-9445 10.1073/pnas.1530509100.
90. Kent WJ, (2002) BLAT-the BLAST-like alignment tool. Genome Res 12 (4): 656-664 10.1101/gr.229202. Article published online before March 2002.
91. Falcon S, Gentleman R, (2007) Using GOstats to test gene lists for GO term association. Bioinformatics 23 (2): 257-258 10.1093/bioinformatics/btl567.
92. Benjamini Y, Yekutieli D, (2001) The control of the false discovery rate in multiple testing under dependency. The Annals of Statistics 29: 1165.
93. Zhang B, Horvath S, (2005) A general framework for weighted gene co-expression network analysis. Stat Appl Genet Mol Biol 4: Article17 10.2202/1544-6115.1128.
94. Langfelder P, Horvath S, (2008) WGCNA: An R package for weighted correlation network analysis. BMC Bioinformatics 9 559: 10.1186/1471-2105-9-559.
95. Mason MJ, Fan G, Plath K, Zhou Q, Horvath S, (2009) Signed weighted gene co-expression network analysis of transcriptional regulation in murine embryonic stem cells. BMC Genomics 10: 327 10.1186/1471-2164-10-327.
96. Langfelder P, Zhang B, Horvath S, (2008) Defining clusters from a hierarchical cluster tree: The dynamic tree cut package for R. Bioinformatics 24 (5): 719-720 10.1093/bioinformatics/btm563.
97. Langfelder P, Horvath S, (2007) Eigengene networks for studying the relationships between co-expression modules. BMC Syst Biol 1: 54 10.1186/1752-0509-1-54.
98. Ghazalpour A, Doss S, Zhang B, Wang S, Plaisier C, et al. (2006) Integrating genetic and network analysis to characterize genes related to mouse weight. PLoS Genet 2 (8): e130 10.1371/journal.pgen.0020130.
99. Mott R, Talbot CJ, Turri MG, Collins AC, Flint J, (2000) A method for fine mapping quantitative trait loci in outbred animal stocks. Proc Natl Acad Sci U S A 97 (23): 12649-12654 10.1073/pnas.230304397.
100. Cox A, Ackert-Bicknell CL, Dumont BL, Ding Y, Bell JT, et al. (2009) A new standard genetic map for the laboratory mouse. Genetics 182 (4): 1335-1344 10.1534/genetics.109.105486.
101. Valdar W, Holmes CC, Mott R, Flint J, (2009) Mapping in structured populations by resample model averaging. Genetics 182 (4): 1263-1277 10.1534/genetics.109.100727.